LinkedIn Profile

Access Xigen historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:xigen 761145 Jun 4th, 2019 12:00AM Xigen 175 6.00 Open Biotechnology Jun 4th, 2019 03:06PM Jun 4th, 2019 03:06PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Open Open CH Health Care Equipment & Services
private:xigen 761145 Feb 17th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 16th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 15th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 14th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 13th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 12th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 11th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 10th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services
private:xigen 761145 Feb 9th, 2018 12:00AM Xigen 135 6.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids. The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.